New immune map uncovers key pancreatic cancer insights

Researchers determine a complex immune infiltrate pattern based on a newly constructed immune map developed using pancreatic cancer cells.

Mainz Biomed Reports Mid-Year 2024 Financial Results and Provides Corporate Update – Biotech Investments

Issuer: Mainz BioMed N.V. / Key word(s): Half Year Results 21.10.2024 / 14:01 CET/CEST The issuer is solely responsible for the content of this announcement.

October 22, 2024

3 Strategies for Implementing Multilingual Healthcare Delivery

Lena Petrova, Founder and CEO of Ad Astra According to the most recent data from the US Census Bureau’s American Community Survey (ACS), 29.6 million

February 6, 2025

Tenofovir Alafenamide Remains the Most Effective Treatment for Chronic HBV

VIENNA — Tenofovir alafenamide (TAF; Biktarvy) continued to be highly effective for chronic hepatitis B virus (HBV) infection for up to 8 years, according to

June 27, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.